日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

前列腺癌异质性的种系和体细胞起源。

Yamaguchi Takafumi N, Houlahan Kathleen E, Zhu Helen, Kurganovs Natalie, Livingstone Julie, Fox Natalie S, Yuan Jiapei, Sietsma Penington Jocelyn, Jung Chol-Hee, Schwarz Tommer, Jaratlerdsiri Weerachai, van Riet Job, Georgeson Peter, Mangiola Stefano, Taraszka Kodi, Lesurf Robert, Jiang Jue, Chow Ken, Heisler Lawrence E, Shiah Yu-Jia, Ramanand Susmita G, Clarkson Michael J, Nguyen Anne, Espiritu Shadrielle Melijah G, Stuchbery Ryan, Jovelin Richard, Huang Vincent, Bell Connor, O'Connor Edward, McCoy Patrick J, Lalansingh Christopher M, Cmero Marek, Salcedo Adriana, Chan Eva K F, Liu Lydia Y, Stricker Phillip D, Bhandari Vinayak, Bornman Riana M S, Sendorek Dorota H S, Lonie Andrew, Prokopec Stephenie D, Fraser Michael, Peters Justin S, Foucal Adrien, Mutambirwa Shingai B A, Mcintosh Lachlan, Orain Michèle, Wakefield Matthew, Picard Valérie, Park Daniel J, Hovington Hélène, Kerger Michael, Bergeron Alain, Sabelnykova Veronica, Seo Ji-Heui, Pomerantz Mark M, Zaitlen Noah, Waszak Sebastian M, Gusev Alexander, Lacombe Louis, Fradet Yves, Ryan Andrew, Kishan Amar U, Lolkema Martijn P, Weischenfeldt Joachim, Têtu Bernard, Costello Anthony J, Hayes Vanessa M, Hung Rayjean J, He Housheng H, McPherson John D, Pasaniuc Bogdan, van der Kwast Theodorus, Papenfuss Anthony T, Freedman Matthew L, Pope Bernard J, Bristow Robert G, Mani Ram S, Corcoran Niall M, Reimand Jüri, Hovens Christopher M, Boutros Paul C

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases

评估罕见蛋白质编码种系变异对 37,184 例前列腺癌风险和严重程度的影响

Mitchell, Jonathan; Camacho, Niedzica; Shea, Patrick; Stopsack, Konrad H; Joseph, Vijai; Burren, Oliver S; Dhindsa, Ryan S; Nag, Abhishek; Berchuck, Jacob E; O'Neill, Amanda; Abbasi, Ali; Zoghbi, Anthony W; Alegre-Díaz, Jesus; Kuri-Morales, Pablo; Berumen, Jaime; Tapia-Conyer, Roberto; Emberson, Jonathan; Torres, Jason M; Collins, Rory; Wang, Quanli; Goldstein, David; Matakidou, Athena; Haefliger, Carolina; Anderson-Dring, Lauren; March, Ruth; Jobanputra, Vaidehi; Dougherty, Brian; Carss, Keren; Petrovski, Slavé; Kantoff, Philip W; Offit, Kenneth; Mucci, Lorelei A; Pomerantz, Mark; Fabre, Margarete A

Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer.

表观遗传分析可识别内分泌耐药性标志物,并为转移性去势抵抗性前列腺癌提供治疗选择

Severson Tesa M, Minnee Emma, Zhu Yanyun, Schuurman Karianne, Nguyen Holly M, Brown Lisha G, Hakkola Sini, Menezes Renee, Gregoricchio Sebastian, Kim Yongsoo, Kneppers Jeroen, Linder Simon, Stelloo Suzan, Lieftink Cor, van der Heijden Michiel S, Nykter Matti, van der Noort Vincent, Sanders Joyce, Morris Ben, Jenster Guido, van Leenders Geert Jlh, Pomerantz Mark, Freedman Matthew L, Beijersbergen Roderick L, Urbanucci Alfonso, Wessels Lodewyk, Nelson Peter S, Corey Eva, Prekovic Stefan, Zwart Wilbert, Bergman Andries M

Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer

生殖系DNA损伤修复变异与高危或转移性前列腺癌患者的预后

Stopsack, Konrad H; Vijai, Joseph; Conry, Michael; Berchuck, Jacob E; Kemel, Yelena; Vasselman, Samantha E; Freeman, Dory A; Lee, Gwo-Shu M; Mandelker, Diana; Solit, David B; Morris, Michael J; Penney, Kathryn L; Abida, Wassim; Offit, Kenneth; Mucci, Lorelei A; Kantoff, Philip W; Pomerantz, Mark M

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial

前列腺癌患者生活质量的遗传驱动因素:E3805 CHAARTED 试验中遗传多态性和患者报告结局的评估

Sentana-Lledo, Daniel; Chu, Xiangying; Ryan, Charles J; Gupta, Arjun; Sweeney, Christopher J; Jarrard, David F; Plimack, Elizabeth R; Gartrell, Benjamin A; Carducci, Michael A; Hussain, Maha; Garcia, Jorge A; Cella, David; DiPaola, Robert S; Pomerantz, Mark; Morgans, Alicia K

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer

寡转移性激素敏感性前列腺癌的固定疗程全身治疗联合转移灶定向放射治疗

Ravi, Praful; Zhong, Caiwei; Xie, Wanling; Kelly, Emma; Whelpley, Bridget; Kuczmarski, Katelyn; Beltran, Himisha; Kilbridge, Kerry L; King, Martin T; McGregor, Bradley A; Morgans, Alicia K; Pomerantz, Mark; Taplin, Mary-Ellen; Tewari, Alok K; Viswanathan, Srinivas R; Wei, Xiao X; Anh Huynh, Mai; Choudhury, Atish D

Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors

通过整合家族史、多基因风险评分、DNA修复基因罕见变异和生活方式因素来识别有早期致命性前列腺癌风险的患者

Zhang, Zhizhu; Zhang, Yiwen; Stopsack, Konrad H; Kibel, Adam S; Giovannucci, Edward L; Penney, Kathryn L; Wang, Anqi; Vijai, Joseph; Kantoff, Philip W; Pomerantz, Mark M; Offit, Kenneth; Mucci, Lorelei A; Plym, Anna

Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping

作者更正:液体活检表观基因组分析用于癌症亚型分类

Baca, Sylvan C; Seo, Ji-Heui; Davidsohn, Matthew P; Fortunato, Brad; Semaan, Karl; Sotudian, Shahabbedin; Lakshminarayanan, Gitanjali; Diossy, Miklos; Qiu, Xintao; El Zarif, Talal; Savignano, Hunter; Canniff, John; Madueke, Ikenna; Saliby, Renee Maria; Zhang, Ziwei; Li, Rong; Jiang, Yijia; Taing, Len; Awad, Mark; Chau, Cindy H; DeCaprio, James A; Figg, William D; Greten, Tim F; Hata, Aaron N; Hodi, F Stephen; Hughes, Melissa E; Ligon, Keith L; Lin, Nancy; Ng, Kimmie; Oser, Matthew G; Meador, Catherine; Parsons, Heather A; Pomerantz, Mark M; Rajan, Arun; Ritz, Jerome; Thakuria, Manisha; Tolaney, Sara M; Wen, Patrick Y; Long, Henry; Berchuck, Jacob E; Szallasi, Zoltan; Choueiri, Toni K; Freedman, Matthew L

Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma.

利用肉瘤样分化的表观基因组特征指导肾细胞癌的治疗

El Zarif Talal, Semaan Karl, Eid Marc, Seo Ji-Heui, Garinet Simon, Davidsohn Matthew P, Sahgal Pranshu, Fortunato Brad, Canniff John, Nassar Amin H, Abou Alaiwi Sarah, Bakouny Ziad, Lakshminarayanan Gitanjali, Savignano Hunter, Lyons Kevin, Matar Sayed, Ali Atef, Saad Eddy, Saliby Renee Maria, Cordeiro Paulo, Zhang Ziwei, El Ahmar Nourhan, Laimon Yasmin Nabil, Labaki Chris, Shah Valisha, Freeman Dory, O'Toole Jillian, Lee Gwo-Shu Mary, Hwang Justin, Pomerantz Mark, Signoretti Sabina, Van Allen Eliezer M, Xie Wanling, Berchuck Jacob E, Viswanathan Srinivas R, Braun David A, Choueiri Toni K, Freedman Matthew L, Baca Sylvan C

Insulin resistance during androgen deprivation therapy in men with prostate cancer

前列腺癌患者接受雄激素剥夺疗法期间的胰岛素抵抗

Basaria, Shehzad; Taplin, Mary-Ellen; McDonnell, Marie; Simonson, Donald C; Lin, Alexander P; Dufour, Alyssa B; Habtemariam, Daniel; Nguyen, Paul L; Ravi, Praful; Kibel, Adam S; Sweeney, Christopher J; D'Amico, Anthony V; Roberts, Daniel A; Xu, Wenxin; Wei, Xiao X; Sunkara, Rajitha; Choudhury, Atish D; Mantia, Charlene; Beltran, Himisha; Pomerantz, Mark; Berchuck, Jacob E; Martin, Neil E; Leeman, Jonathan E; Mouw, Kent W; Kilbridge, Kerry E; Bearup, Richelle; Kackley, Hannah; Kafel, Hussein; Huang, Grace; Reid, Kieran F; Storer, Thomas; Braga-Basaria, Milena; Travison, Thomas G